menu
    • menu

    All Manufacturers, Suppliers, Distributors and Exporters of Abrocitinib with approved Health Canada of Finished Dosage Form listed on PharmaCompass.com

    Client Email Product
    Moehs Abrocitinib

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Metrochem Abrocitinib

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    6

    API Suppliers

    API Suppliers

    2

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    1

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    6

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 0

    MARKET PLACE

    1

    API

    0

    FDF

    1INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    8

    FDF Dossiers

    FDF Dossiers

    3

    FDA Orange Book

    FDA (Orange Book)

    2

    Europe

    Europe

    3

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    13DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    9

    US Patents

    6

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    30

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    1,849,145

    Annual Reports

    128

    Finished Drug Prices

    Listed Dossiers

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Abrocitinib, 1622902-68-4, Pf-04965842, Cibinqo, Abrocitinib [usan], 73sm5sf3or
    Molecular Formula
    C14H21N5O2S
    Molecular Weight
    323.42  g/mol
    InChI Key
    IUEWXNHSKRWHDY-UHFFFAOYSA-N
    FDA UNII
    73SM5SF3OR
    Abrocitinib
    Abrocitinib is under investigation in clinical trial NCT03796676 (JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis).
    Abrocitinib is a Janus Kinase Inhibitor. The mechanism of action of abrocitinib is as a Janus Kinase Inhibitor, and P-Glycoprotein Inhibitor.
    1 2D Structure

    Abrocitinib

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide
    2.1.2 InChI
    InChI=1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)
    2.1.3 InChI Key
    IUEWXNHSKRWHDY-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3
    2.2 Other Identifiers
    2.2.1 UNII
    73SM5SF3OR
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 1-propanesulfonamide, N-(cis-3-(methyl-7h-pyrrolo(2,3-d)pyrimidin-4-ylamino)cyclobutyl)-

    2. Abrocitinib

    3. N-(cis-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-1-propanesulfonamide

    4. N-(cis-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-propane-1-sulfonamide

    5. Pf-04965842

    2.3.2 Depositor-Supplied Synonyms

    1. Abrocitinib

    2. 1622902-68-4

    3. Pf-04965842

    4. Cibinqo

    5. Abrocitinib [usan]

    6. 73sm5sf3or

    7. Chembl4101725

    8. N-[3-[methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide

    9. N-{cis-3-[methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide

    10. 1-propanesulfonamide, N-(cis-3-(methyl-7h-pyrrolo(2,3-d)pyrimidin-4-ylamino)cyclobutyl)-

    11. N-(3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide, Cis-

    12. N-(cis-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide

    13. N-[cis-3-(methyl-7h-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide

    14. Unii-73sm5sf3or

    15. D7d

    16. N-((1s,3s)-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide

    17. N-((1s,3s)-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide

    18. Abrocitinib [inn]

    19. Abrocitinib [jan]

    20. Abrocitinib (jan/usan)

    21. Abrocitinib [who-dd]

    22. Gtpl9991

    23. Chembl3655081

    24. Schembl15970412

    25. Schembl15970413

    26. Pf-04965842(abrocitinib)

    27. Bdbm159748

    28. Dtxsid301126581

    29. Pf-04965842 (abrocitinib)

    30. Bcp30441

    31. Ex-a3037

    32. Xpc90268

    33. Ac8575

    34. Bdbm50243847

    35. Mfcd30187577

    36. S8765

    37. Zb1566

    38. Zinc261115849

    39. Db14973

    40. Sb18849

    41. Compound 25 [pmid: 29298069]

    42. Ncgc00601823-02

    43. Ac-36318

    44. As-84437

    45. Sy248874

    46. Hy-107429

    47. Cs-0028460

    48. Pf04965842

    49. D11400

    50. Us9035074, 2

    51. A936574

    52. Pf-04965842, >=98% (hplc)

    53. Pf-04965842pf-04965842

    54. Pf-04965842; Pf 04965842; Pf04965842

    55. N-(cis-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-1-propanesulfonamide

    56. N-(cis-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-propane-1-sulfonamide

    57. Abrocitinib;n-[cis-3-(methyl-7h-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide

    2.4 Create Date
    2014-10-06
    3 Chemical and Physical Properties
    Molecular Weight 323.42 g/mol
    Molecular Formula C14H21N5O2S
    XLogP31.7
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count6
    Exact Mass323.14159610 g/mol
    Monoisotopic Mass323.14159610 g/mol
    Topological Polar Surface Area99.4 Ų
    Heavy Atom Count22
    Formal Charge0
    Complexity474
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Protein Kinase Inhibitors

    Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)

    5.2 FDA Pharmacological Classification
    5.2.1 Active Moiety
    ABROCITINIB
    5.2.2 FDA UNII
    73SM5SF3OR
    5.2.3 Pharmacological Classes
    Mechanisms of Action [MoA] - P-Glycoprotein Inhibitors
    5.3 ATC Code

    D11AH

    D - Dermatologicals

    D11 - Other dermatological preparations

    D11A - Other dermatological preparations

    D11AH - Agents for dermatitis, excluding corticosteroids

    D11AH08 - Abrocitinib

    API SUPPLIERS

    read-more
    read-more
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    USDMF

    read-more
    read-more

    01

    Moehs Iberica Sl

    Spain
    arrow
    CPhI Worldwide, Milan
    Booth #4A33
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 38879

    Submission : 2023-09-15

    Status : Active

    Type : II

    Moehs Iberica

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ASC 2024
    Not Confirmed

    02

    Changzhou Pharmaceutical Factory

    China
    arrow
    ASC 2024
    Not Confirmed

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 39291

    Submission : 2023-12-27

    Status : Active

    Type : II

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Annual Reports

    read-more
    read-more

    01

    Brand Name : Cibinqo

    Abrocitinib

    arrow
    ASC 2024
    Not Confirmed

    Brand Name : Cibinqo

    U.S.A
    arrow
    ASC 2024
    Not Confirmed

    Pfizer Inc.

    Abrocitinib

    Main Therapeutic Indication : Dermatology

    Currency : USD

    2023 Revenue in Millions : 128

    2022 Revenue in Millions : 27

    Growth (%) : 374

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search